TSHR与自身免疫性甲状腺疾病关系的研究进展
被引量:7
摘要
自身免疫性甲状腺疾病 (AITD)是一组器官特异性自身免疫性疾病 ,促甲状腺素受体 (TSHR)是其重要的自身抗原 ,在遗传和环境因素共同作用下 ,可以诱导机体产生特异性抗体 ,即TSHR抗体 (TRAb) ,它介导损伤性免疫应答。
出处
《国外医学(内分泌学分册)》
2003年第1期40-42,共3页
Foreign Medical Sciences(Section of Endocrinology)
参考文献10
-
1Tomer Y,Barbesino G,Keddache M,et al.Mapping of a major susceptibility locus for Graves’disease (GD-1) to chromosome 14q31[].The Journal of Clinical Endocrinology.1997
-
2Sunthornthepvarakul T,Kitvitayasak S,Ngowngarmaratana S,et al.Lack of association between a polymorphism of human thyrotropin receptor gene and autoimmune thyroid disease[].Journal of the Medical Association of Thailand.1999
-
3Akamizu T,Moriyama K,Miura M,et al.Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TRAbs) derived from lymphocytes of patients with Graves’disease: epitope and binding study of two stimulatory TRAbs[].The Journal of Endocrinology.1999
-
4Simanainen J,Kinch A,Westermark K,et al.Analysis of mutations in exon 1 of the human thyrotropin receptor gene:high frequency of the D36H and P52T polymorphic variants[].Thyroid.1999
-
5Seetharamaiah G S,Dallas J S,Prabhakar B S.Glycosylated ectodomain of the human thyrotropin receptor induces antibodies capable of reacting with multiple blocking antibody epitopes[].Autoimmunity.1999
-
6Schwarz-Lauer L,Chazenbalk G D,Mclachlan S M,et al.Evidence for a simplified view of autoantibody interactions with the thyrotropin receptor[].Thyroid.2002
-
7Shepherd P S,Da Costa C R,Cridland J C,et al.Identification of an important thyrotrophin binding site on the human thyrotrophin receptor using monoclonal antibodies[].Molecular and Cellular Endocrinology.1999
-
8Li X,Lu S,Miyagi E,et al.Thyrotropin prevents apoptosis by promoting cell adhesion and cell cycle progression in FRTL-5[].The Journal of Endocrinology.1999
-
9Abe Y.Apoptosis in the pathogenesis of autoimmune thyroid disease[].Japanese Journal of Clinical Medicine.1999
-
10Chazenbalk G D,McLachlan S M,Pichurin P,et al.A prion-like shift between two conformational forms of a recombinant thyrotropin receptor A-subunit module: purification and stabilization using chemical chaperones of the form reactive with Graves’autoantibodies[].The Journal of Clinical Endocrinology.2001
同被引文献69
-
1何云南.游离三碘甲状腺原氨酸(FT_3)放射免疫分析的临床应用[J].放射免疫学杂志,1995,8(6):458-459. 被引量:1
-
2连小兰,白耀,孙梅励,郭芝生,戴为信.血清抗甲状腺球蛋白抗体和抗甲状腺过氧化物酶抗体测定的临床诊断意义[J].中国医学科学院学报,2004,26(6):677-681. 被引量:38
-
3徐健,刘小立,杨雪锋,李兰英,孙云,孙秀发.过量碘对甲状腺细胞凋亡的影响[J].卫生研究,2007,36(4):443-445. 被引量:14
-
4Tomer Y, Barbesino G, Keddache M, et al. Mapping of a major sus- ceptibility locus for Graves~ disease (GD- 1 ) to chromosome 14q31. J Clin Endocrinol Metab, 1997, 82(5 ): 1645-1648.
-
5AkamizuT, MoriyamaK, MiuraM, et ak Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TSHRAbs)derived from lymphocytes of patients with Graves" disease: epitope and binding study of two stimulatory TSHRAbs. Endocrinology, 1999, 140(4): 1594-1601.
-
6Marians RC, Ng L, Blair HC, et al. Defining thyrotropin-dependent and -independent steps of thyroid hormone synthesis by using thy- rotropin receptor-null mice. Proc Natl Acad Sci USA, 2002, 99 (24): 15776-15781.
-
7Garcia-JimOnez C, Santisteban P. TSH signalling and cancer. Arq Bras Endocrinol Metabol, 2007, 51 (5): 654-671.
-
8Hoffmann S, Maschuw K, Hassan I, et al. Functional thyrotropin receptor attenuates malignant phenotype of follicular thyroid caneer cells. Endocrine, 2006, 30( 1 ): 129-138.
-
9Rivas M, Santisteban P. TSH-activated signaling pathways in thy-roid tumorigenesis. Mol Cell Endocrinol, 2003, 213 ( 1 ): 31-45.
-
10Xing M, Usadel H, Cohen Y, et al. Methylation of the thyroid-stim- ulating hormone receptor gene in epithelial thyroid tumors: a mark- er of malignancy and a cause of gene silencing. Cancer Res, 2003 63(9): 2316-2321.
引证文献7
-
1孙志香,吴嘉,钟惠蕃,马俊.桥本甲状腺炎研究的进展[J].长沙医学院学报,2005(1):6-8.
-
2张华川,陈丽媚,吴多能,符生苗.磁分离酶联免疫测定技术在甲状腺功能监测的临床应用[J].中国热带医学,2005,5(2):265-265.
-
3孙志香,吴嘉,钟惠菊.桥本甲状腺炎研究的进展[J].标记免疫分析与临床,2005,12(4):249-251. 被引量:6
-
4何斐,鲍艳芳,潘瑛瑛,应素芬,张瑾,陶柳萍.峰龄胶囊对自身免疫性甲状腺疾病自身抗体的影响[J].现代中西医结合杂志,2007,16(10):1337-1338. 被引量:1
-
5陈骁熠,严清华,王敏,凌艺辉,姚平,于东,孙秀发.过量碘致甲状腺自体免疫性疾病作用[J].中国公共卫生,2009,25(7):806-808. 被引量:3
-
6程维维,王辉.促甲状腺激素受体与甲状腺癌关系的研究进展[J].国际放射医学核医学杂志,2012,36(2):69-72. 被引量:1
-
7董自蓬,马玲,陈钰琼,丁丽娜,王奕,尚文斌.Graves病患者促甲状腺激素受体抗体与肝功能指标的关系[J].中国现代医学杂志,2020,30(11):43-47. 被引量:6
二级引证文献17
-
1孙策,李新经,骆春艳.硒酵母片联合小剂量^(131)I治疗Graves病合并甲状腺功能亢进的效果及其对血清甲状腺激素水平的影响[J].社区医学杂志,2021,19(6):350-352. 被引量:1
-
2陈海波,胡旦芳.南昌市青山湖区2008~2009年碘盐监测结果分析[J].实验与检验医学,2010,28(3):284-285. 被引量:4
-
3代芳,刘祥秀,李波,邱艳红,李红.理气活血方对桥本甲状腺炎患者临床疗效研究及血清TNF-α的影响[J].辽宁中医杂志,2011,38(4):678-680. 被引量:5
-
4顾群利.甲状腺手术患者不良反应的护理[J].中国实用护理杂志,2011,27(24):26-27. 被引量:16
-
5郑东淑,刘存山,赵德安.桥本甲状腺炎的外科诊治探讨[J].中国中西医结合耳鼻咽喉科杂志,2011,19(4):264-267. 被引量:3
-
6司英奎,刘亚峰,郭雁冰,许继宗,杨建宇,李杨.桥本甲状腺炎的研究进展[J].中国中医药现代远程教育,2011,9(24):143-148. 被引量:2
-
7张颖,李俞莹,姚旋,应浩.碘与甲状腺疾病[J].生命科学,2012,24(8):901-908. 被引量:61
-
8周绍荣,薛慈民.“消瘿扶正方”治疗桥本甲状腺炎30例临床观察[J].江苏中医药,2013,45(9):38-39. 被引量:22
-
9宋补昌,李晓峰,任振援.131^碘治疗Graves病患者后TGAb与TPOAb变化的意义[J].中国实用医刊,2014,41(17):4-5. 被引量:5
-
10黄广英,禤文婷.促甲状腺激素受体在甲状腺癌中的表达及其临床意义[J].中国实用医药,2017,12(7):78-79. 被引量:2
-
1武革,司徒玉,杨健.Graves病患者促甲状腺素受体抗体检测的临床意义[J].广东医学院学报,1995,13(4):289-290.
-
2金更学,徐翔宇,李瑶,陈慧.TSAb诱导的相关信号通路的研究进展[J].医学研究杂志,2017,46(1):15-17. 被引量:1
-
3李滔,李军.促甲状腺素受体抗体检测在Graves诊治中的临床价值[J].长江大学学报(自科版)(下旬),2013,9(2):28-29. 被引量:2
-
4徐卓华,程永福,罗韡英.促甲状腺素受体抗体测定及临床意义[J].安徽医学,1996,17(1):12-14.
-
5叶飞,丁建仁,胡吉星,张秀英,王兴木.Graves病促甲状腺素受体抗体测定的临床意义[J].放射免疫学杂志,1997,10(1):13-14.
-
6仲崇明.甲状腺功能异常患者血清肿瘤坏死因子α的检测及其分析[J].标记免疫分析与临床,2003,10(1):53-54.
-
7徐炜.促甲状腺素受体抗体检测对Graves病患者的诊断价值分析[J].中国现代药物应用,2013,7(24):25-25.
-
8何剑峰.TSHr在Graves眼病发病机制中作用的研究进展[J].广西医学,2005,27(6):863-866. 被引量:1
-
9马晓丹,毛晓健.促甲状腺素受体基因与甲状腺功能亢进症相关性研究进展[J].中华实用儿科临床杂志,2016,31(8):634-637. 被引量:6
-
10戴亚丽,施秉银,薛明战,李雪萍,高慧,何岚,王毅,马秀萍,袁育康.促甲状腺激素受体胞外段基因突变与Graves病的相关研究[J].中华内分泌代谢杂志,2002,18(2):131-132.